Cetera Investment Advisers Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cetera Investment Advisers boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 67,202 shares of the medical equipment provider's stock after buying an additional 3,440 shares during the quarter. Cetera Investment Advisers' holdings in Intuitive Surgical were worth $35,077,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $25,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Finally, BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $28,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, EVP Myriam Curet sold 408 shares of the business's stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now owns 353 shares of the company's stock, valued at approximately $208,181.75. The trade was a 53.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,044 shares of company stock worth $17,070,433 over the last ninety days. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of research analyst reports. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Leerink Partners upped their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Finally, BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $598.95.

Intuitive Surgical Trading Up 4.2%

Shares of Intuitive Surgical stock traded up $22.46 on Monday, reaching $558.97. 1,151,789 shares of the stock were exchanged, compared to its average volume of 1,630,015. Intuitive Surgical, Inc. has a 1-year low of $379.67 and a 1-year high of $616.00. The business has a fifty day moving average price of $500.93 and a two-hundred day moving average price of $535.03. The firm has a market capitalization of $200.35 billion, a PE ratio of 87.28, a PEG ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the business posted $1.50 earnings per share. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.